Bruce Kaplan
#149,272
Most Influential Person Now
Bruce Kaplan's AcademicInfluence.com Rankings
Bruce Kaplanphilosophy Degrees
Philosophy
#8185
World Rank
#11517
Historical Rank
Logic
#5215
World Rank
#6597
Historical Rank
Bruce Kaplanbiology Degrees
Biology
#11045
World Rank
#14420
Historical Rank
Immunology
#706
World Rank
#728
Historical Rank
Download Badge
Philosophy Biology
Bruce Kaplan's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Immunology University of California, San Francisco
Why Is Bruce Kaplan Influential?
(Suggest an Edit or Addition)Bruce Kaplan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era (2004) (1196)
- Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. (2001) (826)
- Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: A Paired Donor Kidney Analysis1 (2002) (710)
- Long‐Term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies? (2004) (603)
- The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. (2002) (553)
- Effect of waiting time on renal transplant outcome. (2000) (536)
- Endothelial Gene Expression in Kidney Transplants with Alloantibody Indicates Antibody‐Mediated Damage Despite Lack of C4d Staining (2009) (450)
- Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. (2000) (414)
- Survival benefit of solid-organ transplant in the United States. (2015) (374)
- Antibody‐Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure (2009) (355)
- Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation1,2 (2003) (345)
- THE IMPACT OF SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION ON LONG-TERM PATIENT SURVIVAL1 (2001) (320)
- Therapeutic Drug Monitoring of Mycophenolate Mofetil in Transplantation (2006) (313)
- Death After Graft Loss: An Important Late Study Endpoint in Kidney Transplantation (2002) (262)
- Strategies for the management of adverse events associated with mTOR inhibitors. (2014) (226)
- Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. (2001) (205)
- Microarray Analysis of Rejection in Human Kidney Transplants Using Pathogenesis‐Based Transcript Sets (2007) (201)
- INCREASED IMPACT OF ACUTE REJECTION ON CHRONIC ALLOGRAFT FAILURE IN RECENT ERA (2000) (198)
- Kidney Transplantation Halts Cardiovascular Disease Progression in Patients with End‐Stage Renal Disease (2004) (190)
- The Broad Spectrum of Quality in Deceased Donor Kidneys (2005) (184)
- Exponentially increased risk of infectious death in older renal transplant recipients. (2001) (178)
- A molecular classifier for predicting future graft loss in late kidney transplant biopsies. (2010) (176)
- Increasing Live Donor Kidney Transplantation: A Randomized Controlled Trial of a Home‐Based Educational Intervention (2007) (174)
- Fixed‐ or Controlled‐Dose Mycophenolate Mofetil with Standard‐ or Reduced‐Dose Calcineurin Inhibitors: The Opticept Trial (2009) (171)
- Increased immunosuppressive vulnerability in elderly renal transplant recipients. (2000) (167)
- Islet Transplantation for Brittle Type 1 Diabetes: The UIC Protocol (2008) (160)
- Are We Frozen in Time? Analysis of the Utilization and Efficacy of Pulsatile Perfusion in Renal Transplantation (2005) (156)
- Diagnosing Rejection in Renal Transplants: A Comparison of Molecular‐ and Histopathology‐Based Approaches (2009) (153)
- The effect of body mass index on long-term renal allograft survival. (1999) (153)
- The Effect of Renal Insufficiency on Mycophenolic Acid Protein Binding (1999) (152)
- Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post‐transplant year: Pharmacokinetics, exposure‐response relationships, and influence on cyclosporine (2001) (152)
- Pharmacology of calcineurin antagonists. (2004) (146)
- Poor Predictive Value of Serum Creatinine for Renal Allograft Loss (2003) (142)
- Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. (2004) (136)
- Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range. (2002) (135)
- BASILIXIMAB VERSUS ANTITHYMOCYTE GLOBULIN FOR PREVENTION OF ACUTE RENAL ALLOGRAFT REJECTION1,2 (2001) (135)
- Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration1 (2003) (133)
- Relationship of recipient age and development of chronic allograft failure. (2000) (131)
- Renal transplantations performed using non–heart-beating organ donors: going back to the future?1 (2002) (130)
- Sirolimus in Combination with Tacrolimus Is Associated with Worse Renal Allograft Survival Compared to Mycophenolate Mofetil Combined with Tacrolimus (2005) (129)
- A randomized trial of a home-based educational approach to increase live donor kidney transplantation: effects in blacks and whites. (2008) (119)
- Long‐Term Use of Mycophenolate Mofetil is Associated With a Reduction in the Incidence and Risk of Late Rejection (2003) (118)
- Long-term graft survival with neoral and tacrolimus: a paired kidney analysis. (2003) (116)
- Biomarkers for kidney transplant rejection (2014) (115)
- Association of antibody induction with short- and long-term cause-specific mortality in renal transplant recipients. (2002) (115)
- Tacrolimus Predose Concentrations Do Not Predict the Risk of Acute Rejection After Renal Transplantation: A Pooled Analysis From Three Randomized‐Controlled Clinical Trials † (2013) (113)
- Improvement in hypercalcemia with cinacalcet after kidney transplantation. (2006) (112)
- Hypercoagulable states in renal transplant candidates: impact of anticoagulation upon incidence of renal allograft thrombosis. (2001) (110)
- The Transcriptome of the Implant Biopsy Identifies Donor Kidneys at Increased Risk of Delayed Graft Function (2007) (102)
- Therapeutic monitoring of mycophenolate mofetil. (2006) (102)
- Living Donor Kidney Transplantation Across Positive Crossmatch: The University of Illinois at Chicago Experience (2009) (101)
- Pharmacokinetics of mycophenolic acid in renal insufficiency. (2000) (100)
- Interaction Between Donor and Recipient Age in Determining the Risk of Chronic Renal Allograft Failure (2002) (100)
- RAD IN DE NOVO RENAL TRANSPLANTATION: COMPARISON OF THREE DOSES ON THE INCIDENCE AND SEVERITY OF ACUTE REJECTION 1 (2001) (99)
- Molecular Correlates of Scarring in Kidney Transplants: The Emergence of Mast Cell Transcripts (2008) (98)
- Excellent outcome of renal transplantation in patients with Fabry's disease. (2000) (97)
- Why hasn't eliminating acute rejection improved graft survival? (2007) (89)
- Infectious complications in geriatric renal transplant patients: comparison of two immunosuppressive protocols. (1999) (86)
- GENDER DIFFERENCES IN THE RISK FOR CHRONIC RENAL ALLOGRAFT FAILURE (2001) (86)
- Hepatitis C antibody status and outcomes in renal transplant recipients. (2001) (86)
- Cluster Analysis of Lesions in Nonselected Kidney Transplant Biopsies: Microcirculation Changes, Tubulointerstitial Inflammation and Scarring (2010) (82)
- Decreased protein binding of mycophenolic acid associated with leukopenia in a pancreas transplant recipient with renal failure. (1998) (80)
- Successful Rescue of Refractory, Severe Antibody Mediated Rejection with Splenectomy (2007) (79)
- Renal allograft survival in patients with oxalosis. (2002) (77)
- Inflammation Lesions in Kidney Transplant Biopsies: Association with Survival Is Due to the Underlying Diseases (2011) (77)
- Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT): A Phase 2 Trial of Stable Renal Transplant Recipients (2013) (76)
- Effect of mycophenolate mofetil on long-term outcomes in African american renal transplant recipients. (2000) (75)
- Mycophenolate mofetil in solid-organ transplantation (2003) (73)
- Global Transplantation COVID Report March 2020 (2020) (72)
- Sirolimus with Neoral Versus Mycophenolate Mofetil with Neoral is Associated with Decreased Renal Allograft Survival (2004) (71)
- Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes. (2014) (70)
- The role of PCR in the diagnosis and management of CMV in solid organ recipients: what is the predictive value for the development of disease and should PCR be used to guide antiviral therapy? (1997) (70)
- 2007 Update on Allogeneic Islet Transplantation from the Collaborative Islet Transplant Registry (CITR) (2009) (69)
- Molecular correlates of renal function in kidney transplant biopsies. (2009) (68)
- Recent Developments in Kidney Transplantation—A Critical Assessment (2009) (66)
- Kidneys from Deceased Donors: Maximizing the Value of a Scarce Resource (2005) (65)
- Increasing the Use of Kidneys From Unconventional and High‐Risk Deceased Donors (2016) (65)
- Renal Allograft Survival in Transplant Recipients with Focal Segmental Glomerulosclerosis (2003) (65)
- Pharmacokinetics of an Everolimus‐Cyclosporine Immunosuppressive Regimen Over the First 6 Months After Kidney Transplantation (2003) (64)
- Efficacy and Safety of Everolimus Plus Low‐Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard‐Dose Tacrolimus in De Novo Renal Transplant Recipients: 12‐Month Data (2017) (64)
- Toxicity and efficacy of sirolimus: relationship to whole-blood concentrations. (2000) (63)
- Defining the Canonical Form of T‐Cell‐Mediated Rejection in Human Kidney Transplants (2010) (63)
- Direct and Indirect Costs Following Living Kidney Donation: Findings From the KDOC Study (2016) (60)
- Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients. (2001) (59)
- Low bioavailability of cyclosporine microemulsion and tacrolimus in a small bowel transplant recipient: possible relationship to intestinal P-glycoprotein activity. (1999) (59)
- Prevalence of cytomegalovirus in the gastrointestinal tract of renal transplant recipients with persistent abdominal pain. (1999) (57)
- An overview of frailty in kidney transplantation: measurement, management and future considerations. (2020) (56)
- Patients' Willingness to Talk to others about Living Kidney Donation (2008) (54)
- Preemptive Retransplantation for BK Virus Nephropathy: Successful Outcome Despite Active Viremia (2006) (53)
- Cyclosporine Microemulsion and Tacrolimus are Associated with Decreased Chronic Allograft Failure and Improved Long‐term Graft Survival as Compared with Sandimmune (2002) (53)
- Patients' willingness to talk to others about living kidney donation. (2008) (53)
- Marked Variation of the Association of ESRD Duration Before and After Wait Listing on Kidney Transplant Outcomes (2010) (52)
- Access to quality: evaluation of the allocation of deceased donor kidneys for transplantation. (2005) (51)
- Deleterious effect of waiting time on renal transplant outcome. (2001) (51)
- Randomized calcineurin inhibitor cross over study to measure the pharmacokinetics of co‐administered enteric‐coated mycophenolate sodium (2005) (51)
- Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients (2001) (48)
- Perceptions and Practices Regarding Frailty in Kidney Transplantation: Results of a National Survey (2020) (48)
- Overview of Large Database Analysis in Renal Transplantation (2003) (47)
- Death after graft loss: a novel endpoint for renal transplantation. (2001) (46)
- Interaction between acute rejection and recipient age on long-term renal allograft survival. (2001) (45)
- Mycophenolic acid trough level monitoring in solid organ transplant recipients treated with mycophenolate mofetil: association with clinical outcome (2006) (45)
- The survival outcomes following liver transplantation (SOFT) score: validation with contemporaneous data and stratification of high‐risk cohorts (2013) (44)
- Kidneys from deceased donors: maximizing the value of a scarce resource. (2006) (44)
- Immunosuppression in Elderly Renal Transplant Recipients (2001) (44)
- Renal transplantation: a half century of success and the long road ahead. (2004) (42)
- Combined Liver-Kidney Transplants: Allosensitization and Recipient Outcomes (2011) (42)
- Do Report Cards Influence Hospital Choice? The Case of Kidney Transplantation (2006) (42)
- African-American renal transplant recipients experience decreased risk of death due to infection: possible implications for immunosuppressive strategies. (2000) (41)
- Antibody-Mediated Rejection: Pathogenesis, Prevention, Treatment, and Outcomes (2012) (41)
- The Impact of Mycophenolate Mofetil on Long-Term Outcomes in Kidney Transplantation (2005) (40)
- Transmission of Balamuthia mandrillaris by Organ Transplantation. (2016) (40)
- INTERACTION OF MYCOPHENOLATE MOFETIL AND HLA MATCHING ON RENAL ALLOGRAFT SURVIVAL (2001) (40)
- Post hoc analyses: after the facts. (2015) (40)
- A limited sampling strategy for the estimation of eight-hour neoral areas under the curve in renal transplantation. (1998) (39)
- Effect of Sirolimus Withdrawal in Patients with Deteriorating Renal Function (2004) (39)
- Relationship of Tacrolimus Exposure and Mycophenolate Mofetil Dose With Renal Function After Renal Transplantation (2011) (39)
- Potential Impact of Risk and Loss Aversion on the Process of Accepting Kidneys for Transplantation (2017) (38)
- The effects of renal transplantation on peripheral blood dendritic cells (2005) (38)
- An economic and quality-of-life assessment of basiliximab vs antithymocyte globulin immunoprophylaxis in renal transplantation. (2001) (37)
- A Statistical Comparative Assessment of Face and Hand Transplantation Outcomes to Determine Whether Either Meets the Standard of Care Threshold (2016) (37)
- Dendritic Cell Deficiency Associated With Development of BK Viremia and Nephropathy in Renal Transplant Recipients (2010) (36)
- Predonation Direct and Indirect Costs Incurred by Adults Who Donated a Kidney: Findings From the KDOC Study (2015) (35)
- Early liver retransplantation in adults (2014) (35)
- The Elephant in the Room: Failings of Current Clinical Endpoints in Kidney Transplantation (2010) (35)
- Primum Non Nocere: Is Chronic Kidney Disease Staging Appropriate in Living Kidney Transplant Donors? (2009) (35)
- Pharmacokinetic Principles of Immunosuppressive Drugs (2005) (35)
- Overcoming barriers to long-term graft survival. (2006) (34)
- The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome. (1995) (34)
- Mycophenolate mofetil vs azathioprine in a large population of elderly renal transplant patients. (2004) (34)
- The Financial Burden of Transplantation: A Single-Center Survey of Liver and Kidney Transplant Recipients (2007) (33)
- Potential interaction of troglitazone and cyclosporine. (1998) (33)
- AZA/Tacrolimus Is Associated with Similar Outcomes as MMF/Tacrolimus among Renal Transplant Recipients (2009) (33)
- Lies, Damn Lies, and Statistics: The Perils of the P Value (2006) (32)
- The effect of Daclizumab in a high‐risk renal transplant population (2000) (32)
- Assessing Long‐Term Nephron Loss: Is It Time to Kick the CAN Grading System? (2004) (31)
- Reduction in Carotid Intima-Media Thickness After Pancreatic Islet Transplantation in Patients With Type 1 Diabetes (2013) (31)
- The Islet Transplant Experiment: Time for a Reassessment (2007) (31)
- Evaluation of Drug Interaction Software to Identify Alerts for Transplant Medications (2005) (29)
- Geographic Inequities in Liver Allograft Supply and Demand: Does it Affect Patient Outcomes? (2015) (28)
- The prevalence and implications of BK virus replication in non-renal solid organ transplant recipients: A systematic review. (2015) (28)
- Use of high‐dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation (2008) (28)
- Immunosuppressive strategies to improve outcomes of kidney transplantation. (2007) (27)
- Human granulocytic ehrlichiosis in a renal transplant patient: case report and review of the literature. (1997) (27)
- Lessons Learned in Pediatric Small Bowel and Liver Transplantation From Living-Related Donors (2009) (27)
- Factors Associated With Long-Term Renal Allograft Survival (2002) (27)
- Pregnancy Outcomes Related to Mycophenolate Exposure in Female Kidney Transplant Recipients (2017) (26)
- The expectancies of living kidney donors: do they differ as a function of relational status and gender? (2006) (25)
- KDPI and Donor Selection (2014) (25)
- A case of thrombotic microangiopathy associated with antiphospholipid antibody syndrome successfully treated with eculizumab. (2014) (25)
- Transplantation: Neural networks for predicting graft survival (2009) (24)
- Allograft loss in renal transplant recipients with Fabry's disease and activated protein C resistance. (2000) (24)
- Health‐related quality of life and employment among renal transplant recipients (2012) (24)
- Acyclovir triphosphate inhibits the diagnostic polymerase chain reaction for cytomegalovirus. (1996) (24)
- Analytic Requirements for Immunosuppressive Drugs in Clinical Trials (1995) (24)
- A limited sampling strategy for estimating sirolimus area-under-the-concentration curve. (1997) (24)
- The New OPTN Kidney Allocation Policy: Potential for Inequitable Access Among Highly Sensitized Patients (2015) (24)
- Mood, body image, fear of kidney failure, life satisfaction, and decisional stability following living kidney donation: Findings from the KDOC study (2018) (23)
- Measuring the Expectations of Kidney Donors: Initial Psychometric Properties of the Living Donation Expectancies Questionnaire (2008) (23)
- Long-term benefit of kidney-pancreas transplants in type 1 diabetics. (2001) (22)
- Single‐dose rATG induction at renal transplantation: superior renal function and glucoregulation with less hypomagnesemia (2012) (22)
- Progression of Interstitial Fibrosis during the First Year after Deceased Donor Kidney Transplantation among Patients with and without Delayed Graft Function. (2016) (22)
- HLA Population Genetics in Solid Organ Transplantation (2017) (21)
- Concurrent validity of kidney transplant questionnaire in US renal transplant recipients (2011) (21)
- Recipient age as an independent risk factor for chronic renal allograft failure. (2001) (21)
- Tolerance Versus Immunosuppression: A Perspective (2008) (21)
- Patient-reported outcomes for open versus laparoscopic living donor nephrectomy. (2006) (20)
- Withdrawal of mycophenolate mofetil in stable renal transplant recipients. (2000) (20)
- SEX AND ETHNICITY MAY CHIEFLY INFLUENCE THE INTERACTION OF FLUCONAZOLE WITH CALCINEURIN INHIBITORS12 (2001) (19)
- Time to first graft loss as a risk factor for second renal allograft loss. (2001) (19)
- Histopathology and Immunophenotype of the Spleen During Acute Antibody‐Mediated Rejection (2010) (19)
- Modeling the Allocation System: Principles for Robust Design Before Restructuring (2015) (19)
- Biomarker Guidelines for High-Dimensional Genomic Studies in Transplantation: Adding Method to the Madness (2017) (19)
- Mycophenolate mofetil decreases the risk for chronic renal allograft failure. (2001) (18)
- A critical analysis of early death after adult liver transplants (2013) (18)
- The role of ABO-incompatible living donors in kidney transplantation: state of the art. (2007) (18)
- Transplantation: Biomarkers in transplantation—the devil is in the detail (2015) (18)
- Initial results of solitary pancreas transplants performed without regard to donor/recipient HLA mismatching. (2000) (18)
- If You're Not Fit, You Mustn't Quit: Observational Studies and Weighing the Evidence (2011) (18)
- Removal of basiliximab by plasmapheresis. (2001) (17)
- Histologic Findings from Positive Crossmatch or ABO‐Incompatible Renal Allografts: Accomodation or Chronic Allograft Injury? (2006) (17)
- Immunosuppression reduction for BK virus nephropathy: a case for caution (2007) (17)
- Treating tobacco use and dependence in kidney transplant recipients: development and implementation of a program. (2006) (16)
- Unintended Consequences of the New National Kidney Allocation Policy in the United States (2015) (16)
- Mycophenolic Acid Exposure in High- and Low-Weight Renal Transplant Patients After Dosing With Mycophenolate Mofetil in the Opticept Trial (2010) (16)
- Cardiorespiratory Fitness (Peak Oxygen Uptake): Safe and Effective Measure for Cardiovascular Screening Before Kidney Transplant (2018) (16)
- Use of low dose tacrolimus, mycophenolate mofetil and maintenance IL‐2 receptor blockade in an islet transplant recipient (2007) (16)
- Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients (2013) (15)
- Design and Analysis of Clinical Trials in Transplantation: Principles and Pitfalls (2008) (15)
- Need for individualized immunosuppression in elderly renal transplant recipients. (2001) (15)
- Therapeutic Monitoring of Mycophenolic Acid: Is There Clinical Utility? (2007) (15)
- Immunotherapy in Transplantation (2010) (15)
- Cell Population in Spleens During Antibody-Mediated Rejection: Pathologic and Clinical Findings (2012) (14)
- Cutaneous Toxicities From Transplantation‐Related Medications (2017) (14)
- A Primer on Bayesian Decision Analysis With an Application to a Kidney Transplant Decision (2016) (14)
- Belatacept: The Promises and Challenges of Belatacept and Costimulatory Blockade (2010) (13)
- The Time Is Now: Formation of True Transplant Centers (2008) (13)
- Seeing the Forest for the Trees: Random Forest Models for Predicting Survival in Kidney Transplant Recipients. (2020) (13)
- Survival Benefit of Living-Donor Liver Transplant (2022) (13)
- A Practical Guide to the Clinical Implementation of Biomarkers for Subclinical Rejection Following Kidney Transplantation (2019) (13)
- Results of Positive Cross‐Match Transplantation in African American Renal Transplant Recipients (2008) (13)
- Correlation between pretransplantation test dose cyclosporine pharmacokinetic profiles and posttransplantation sirolimus blood levels in renal transplant recipients. (1999) (13)
- A Limited Sampling Strategy for the Estimation of 12‐Hour SangCya and Neoral AUCs in Renal Transplant Recipients (1999) (13)
- Mycophenolate Mofetil Monitoring: Is There Evidence That It Can Improve Outcomes? (2011) (12)
- Common Errors in the Implementation and Interpretation of Microarray Studies (2015) (12)
- Early Conversion to Belatacept in Kidney Transplant Recipients With Low Glomerular Filtration Rate (2017) (12)
- Evaluation of Accepting Kidneys of Varying Quality for Transplantation or Expedited Placement With Decision Trees (2019) (11)
- Assessing 30‐Day Hospital Readmission After Renal Transplantation: A Complex Task (2012) (11)
- Preservation of Long‐term Renal Allograft Survival: A Challenge for the Years to Come (2005) (11)
- Developments in Clinical Islet, Liver Thoracic, Kidney and Pancreas Transplantation in the Last 5 Years (2006) (11)
- Multivariable Regression Models in Clinical Transplant Research: Principles and Pitfalls (2015) (10)
- Trials and Tribulations of Steroid Withdrawal After Kidney Transplantation (2008) (10)
- Immunosuppression in Cardiac Transplantation: Science, Common Sense and the Heart of the Matter (2006) (10)
- Late-onset renal vein thrombosis: A case report and review of the literature (2014) (9)
- Efficacy of Daclizumab in an African-American and Hispanic renal transplant population (2000) (9)
- Transplant Immunosuppressive Drug Trials on Trial (2004) (9)
- Patterns and predictors of fatigue following living donor nephrectomy: Findings from the KDOC Study (2020) (9)
- Reported Isolated Pancreas Rejection Is Associated With Poor Kidney Outcomes in Recipients of a Simultaneous Pancreas Kidney Transplant (2008) (9)
- Prophylaxis versus Preemptive Protocols for CMV: Do They Impact Graft Survival? (2008) (9)
- Mortality After Kidney Transplantation: What Lessons Can We Learn from Regional and Country Variation? (2006) (9)
- Transplantation: mTOR inhibition in kidney transplant recipients (2011) (9)
- A Surge in cadaveric liver donors and a national narcotic epidemic: Is there an association? (2017) (8)
- A Primer on Machine Learning. (2020) (8)
- The kidney allocation system claims equity: It is time to review utility and fairness (2017) (8)
- A MULTICENTER, RANDOMIZED TRIAL OF SIMULECT® WITH EARLY NEORAL® VS. ATGAM® WITH DELAYED NEORAL® IN RENAL TRANSPLANTATION. A 6-MONTH INTERIM ANALYSIS. (1999) (8)
- Treating Tobacco Use and Dependence in Kidney Transplant Recipients: Development and Implementation of a Program (2006) (8)
- Is Skin the Most Allogenic Tissue in Vascularized Composite Allotransplantation and a Valid Monitor of the Deeper Tissues? (2019) (8)
- P Value: Significance Is Not All Black and White. (2016) (8)
- Role of Anti— Interleukin-2 Receptor Antibodies in Kidney Transplantation (2012) (8)
- Comparing kidney transplant outcomes; caveats and lessons. (2013) (7)
- The advantage of live-donor kidney transplantation in older recipients (2009) (7)
- PANCREAS AFTER KIDNEY TRANSPLANTATION: A SIGNIFICANT RISK FACTOR FOR RENAL ALLOGRAFT LOSS (2004) (7)
- Unmasking of primary hyperaldosteronism by renal transplantation. (2000) (7)
- Novel immunosuppressive strategies for composite tissue allografts (2014) (7)
- Soluble ST2 does not change cardiovascular risk prediction compared to cardiac troponin T in kidney transplant candidates (2017) (7)
- Inhibition of human serum mediated lysis of porcine endothelial cells using a novel peptide which blocks C1Q binding to xenoantibody. (1997) (7)
- The Search for CNI‐Free Immunosuppression: No Free Lunch (2011) (7)
- Artificial Intelligence-related Literature in Transplantation: A Practical Guide. (2020) (7)
- Renal Transplant Outcomes in Waitlist Candidates with a Previous Inactive Status Due to Being Temporarily Too Sick. (2014) (6)
- Electrolyte Imbalances in Pediatric Living Related Small Bowel Transplantation (2008) (6)
- Lessons from the CAESAR Study: Calcineurin Inhibitors—Can't Live with Them and Can't Live without Them (2007) (6)
- MULTICENTER, RANDOMIZED, DOUBLE‐BLIND, DOSEFINDING STUDY EVALUATING THE EFFICACY AND SAFETY OF RAD001 (RAD) IN DE NOVO RENAL TRANSPLANT RECIPIENTS.: Abstract# 954 (2000) (6)
- Program-specific Reports: A Guide to the Debate (2015) (6)
- Decade in review—renal transplantation: A spectrum of advances in renal transplantation (2015) (6)
- The Noninferiority Trial: Don't Don't Do It (2010) (6)
- Changes in Pre- and Post-Exercise Gene Expression among Patients with Chronic Kidney Disease and Kidney Transplant Recipients (2016) (6)
- Pain expectancy, prevalence, severity, and patterns following donor nephrectomy: Findings from the KDOC Study (2020) (6)
- Advantages of living donor kidney transplantation in the current era (2005) (5)
- Native Renal Cysts and Dialysis Duration Are Risk Factors for Renal Cell Carcinoma in Renal Transplant Recipients (2011) (5)
- FDA jeopardizes the lives of lung transplant recipients and in the process severely increases the cost to develop new immunosuppression (2018) (5)
- An Introduction to Basic Pharmacokinetics (2015) (5)
- ABO incompatible renal transplantation in an HIV-seropositive patient. (2008) (5)
- Living Kidney Donor Profile Index: Utility and Limitations (2016) (5)
- OPTICEPT TRIAL: INTERIM ANALYSIS OF RENAL FUNCTION AFTER 6 MONTHS OF MONITORED MYCOPHENOLATE MOFETIL IN COMBINATION WITH CNI IN RENAL TRANSPLANTATION. (2006) (5)
- OPTICEPT TRIAL: EFFICACY AND SAFETY OF MONITORED MMF IN COMBINATION WITH CNI IN RENAL TRANSPLANTATION AT 1 AND 2 YEARS: 862 (2008) (5)
- EFFECT OF WAITING TIME AND PRIMARY RENAL DISEASE ON MORTALITY AFTER RENAL TRANSPLANTATION.: Abstract# 579 (2000) (5)
- Efficacy and Safety of Everolimus With Low-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Randomized Study.: Abstract# 713 (2014) (5)
- Tacrolimus and Sirolimus: When Bad Things Happen to Good Drugs (2006) (5)
- A Primer of Neoclassical (Traditional) and Behavioral Economic Principles for Organ Transplantation: Part 1. (2015) (5)
- Transplantation in 2011: New agents, new ideas and new hope (2012) (5)
- Ethical Considerations Regarding Disparities Pertaining to Kidney Transplant Patients (2011) (4)
- A Call to Accountability: Reporting Outcomes in Vascularized Composite Allotransplantation (2019) (4)
- Enteric-coated Mycophenolate Sodium (myfortic®): An Overview of Current and Future Use in Transplantation (2006) (4)
- Reliability of Medicare claim forms for outcome studies in kidney transplant recipients: epidemiology in clinical outcome trials. (2009) (4)
- THE EFFECTS OF RENAL TRANSPLANTATION ON CIRCULATING PRECURSOR DENDRITIC CELLS. (2004) (4)
- Everolimus-Facilitated Tacrolimus Minimization Preserves Renal Function in De Novo Renal Transplant Recipients.: Abstract# B962 (2014) (4)
- Everolimus in renal transplantation (2002) (4)
- Belatacept in renal transplantation (2011) (4)
- Aggressive post‐transplant monitoring of more importance to successful outcome following re‐transplantation for BK virus nephropathy than absence of pretransplant viremia (2008) (4)
- Influence of Induction Therapy On the Efficacy of Everolimus vs Mycophenolate Based Regimen in De Novo Renal Transplant Recipients.: Abstract# B966 (2014) (3)
- Pre‐transplant myeloid dendritic cell deficiency associated with cytomegalovirus infection and death after kidney transplantation (2012) (3)
- The Impact of COVID-19 on the State of Clinical and Laboratory Research Globally in Transplantation in May 2020 (2020) (3)
- Organ Transplantation: An Introduction to Game Theory. (2015) (3)
- Is Recipient HLA-B51 Status Protective for the Risk of BK Infection After Kidney Transplantation? (2018) (3)
- Urinary Biomarkers and Kidney Transplant Rejection: Fine‐Tuning the Radar (2013) (3)
- A Primer of Neoclassical (Traditional) and Behavioral Economic Principles for Organ Transplantation: Part 2. (2015) (3)
- Rates of Living Kidney Donor Follow-up: Findings From the KDOC Study. (2019) (3)
- Transplantation: Utilizing the transcriptome to predict allograft fibrosis (2016) (3)
- The Optimal MMF Dose in Tacrolimus Treated Patients (2014) (3)
- Risky Business: Models of Risk in Transplant (2013) (3)
- Reduction in Carotid Intima-Media Thickness After Pancreatic Islet Transplantation in Patients With Type 1 Diabetes. Diabetes Care 2013;36:450–456 (2014) (3)
- Polyclonal and monoclonal antibodies in renal transplant: an update (2015) (3)
- American Society for Reconstructive Transplantation Conference Abstracts 2018 (2018) (3)
- STEADY-STATE PHARMACOKINETICS OF ENTERIC-COATED MYCOPHENOLATE SODIUM (MYFORTIC®) IN STABLE RENAL TRANSPLANT PATIENTS DIFFER DURING CONCOMITANT TREATMENT WITH NEORAL® OR TACROLIMUS (2004) (3)
- Panresistant Cytomegalovirus in a Kidney Transplant Recipient (2014) (3)
- Patient-Reported Outcomes for Open versus Laparoscopic Living Donor Nephrectomy (2006) (3)
- Report Cards and Quality: Do Center Report Cards Predict Quality or Simply Predict the Next Report Card? (2014) (3)
- INCIDENCE OF GASTROINTESTINAL CYTOMEGALOVIRUS IN RENAL TRANSPLANT RECIPIENTS WITH ABDOMINAL PAIN ON MYCOPHENOLATE MOFETIL (1998) (2)
- Handling of Missing Data. (2019) (2)
- Management of the Wound Complications in De Novo Renal Transplant Recipients: US92 12-Month Randomized Study.: Abstract# B975 (2014) (2)
- Renal transplantation at the University of Michigan 1964 to 1999. (1999) (2)
- Biomarkers and Kidney Transplant: Time for a New Paradigm? (2018) (2)
- Current State of Evidence on Kidney Transplantation: How Fragile Are the Results? (2021) (2)
- Reporting and Handling of Missing Participant Data in Systematic Reviews of Kidney Transplant Studies (2020) (2)
- LONGITUDINAL ASSESSMENT OF THE STEADY‐STATE PHARMACOKINETICS OF RAD IN DE NOVO RENAL TRANSPLANT PATIENTS.: Abstract# 160 Poster Board #‐Session: P7‐I (2000) (2)
- The Specificity of Monoclonal Fluorescence Polarization Immunoassay for Cyclosporine in Recipients of Simultaneous Pancreas‐Kidney Transplants (1995) (2)
- A Flow Dynamic Rationale for Accelerated Vascularized Composite Allotransplant Rejection (2019) (2)
- Mortality risk assessment after renal transplantation. (2002) (2)
- Personalized physical rehabilitation program and employment in kidney transplant recipients: a randomized trial (2021) (2)
- Graft and Patient Survival (2014) (1)
- Efficacy of Daclizumab in an African‐American and Hispanic renal transplant population (2000) (1)
- COVID-19: a year on. (2020) (1)
- A cautionary tale of BK virus (2013) (1)
- Donor Hypothermia and Organ Transplantation. (2018) (1)
- The Role of Allograft Nephrectomy in the Failing Kidney Transplant. (2023) (1)
- VO2peak prior to transplant differentiates survival post kidney transplant (2021) (1)
- EFFECT OF BODY MASS INDEX ON LONG TERM RENAL GRAFT SURVIVAL (1999) (1)
- Comprar Immunotherapy In Transplantation. Principles And Practice | Bruce Kaplan | 9781405182713 | Wiley (2012) (1)
- Reduced Incidence of CMV and BK Virus Infection With Everolimus vs Mycophenolate Based Regimen in De Novo Renal Transplant Recipients.: Abstract# B959 (2014) (1)
- Immunosuppressive Agents and CMV Risk in the VICTOR Study (2010) (1)
- EFFICACY OF DACLIZUMAB IN A HIGH RISK INNER CITY AFRICAN AMERICAN AND HISPANIC RENAL TRANSPLANT POPULATION (1999) (1)
- IMPACT OF TRANSPLANT TYPES ON LONG‐TERM MORTALITY IN TYPE 1 DIABETICS WITH END‐STAGE NEPHROPATHY.: Abstract# 612 (2000) (1)
- IMPACT OF ANTICOAGULATION ON INCIDENCE OF ALLOGRAFT THROMBOSIS IN RENAL TRANSPLANT RECIPIENTS WITH HYPERCOAGULABLE STATES.: Abstract# 981 (2000) (1)
- Are we making progress in kidney transplantation? (2006) (1)
- DACLIZUMAB DECREASES ACUTE REJECTION IN AFRICAN AMERICAN AND HISPANIC RENAL TRANSPLANT RECIPIENTS.: Abstract# 165 Poster Board #‐Session: P12‐I (2000) (1)
- COMBINED LIVER-KIDNEY TRANSPLANTS: DO LIVERS ALWAYS PROTECT KIDNEYS IN ALLOSENSITIZED RECIPIENTS?: 1521 (2010) (1)
- Differences in etiology for graft loss in female renal transplant recipients. (2001) (1)
- Renal transplantation in the elderly (2006) (1)
- Cyclosporine microemulsion and tacrolimus are associated with decreased chronic allograft failure and improved long-term graft survival as compared to Sandimmune. (2001) (1)
- Routine use of ureteral stents may not be indicated after kidney transplant (2007) (1)
- The practical utility of an economic analysis of calcineurin withdrawal following renal transplantation. (2008) (1)
- WITHDRAWAL OF MYCOPHENOLATE MOFETIL IN STABLE RENAL TRANSPLANT RECIPIENTS.: Abstract# 81 (2000) (1)
- Prevalence and progression of intraductal papillary mucinous neoplasms of the pancreas in solid organ transplant recipients: A systematic review. (2023) (1)
- A limited sampling strategy to predict the Sang-35 area under the curve in adult renal transplant recipients (1998) (1)
- WITHDRAWAL OF MYCOPHENOLATE MOFETIL IN STABLE RENAL TRANSPLANT PATIENTS (1999) (1)
- Clinical Pharmacologic Principles and Immunosuppression (2011) (0)
- SYNERGISTIC INTERACTION BETWEEN DONOR AND RECIPIENT AGE ON LONG‐TERM RENAL ALLOGRAFT SURVIVAL.: Abstract# 582 (2000) (0)
- EXCELLENT RENAL FUNCTION AT 1 YEAR AFTER LDKT IN PATIENTS WITH + CROSS-MATCH SUCCESSFULLY CONVERTED TO NEGATIVE BY PRE-OP PLASMAPHERESIS. (2006) (0)
- The Problem With Predicting Uncommon Events: The Critical Effect of Prevalence in Test Performance. (2022) (0)
- SIROLIMUS IN COMBINATION WITH CYCLOSPORINE MICROEMULSION VERSUS MYCOPHENOLATE MOFETIL WITH CYCLOSPORINE MICROEMULSION IS ASSOCIATED WITH DECREASED GRAFT SURVIVAL IN RENAL TRANSPLANT RECIPIENTS, INDEPENDENT OF ETHNICITY AND DONOR TYPE (2004) (0)
- Toxic effects of imm U flO 5 U ppressive drugs : mechanisms and strategies for controlling them (2004) (0)
- A PHASE I/II DOSE ESCALATION STUDY OF THE HUMANIZED ANTICD3 ANTIBODY HUM291.: Abstract# 578 (2000) (0)
- Discontinuing Mycophenolate With Respect to Pregnancy and the Interpretation of Voluntary Registry Results (2017) (0)
- Pre-Transplant Myeloid Dendritic Cell Deficiency Associated with Cytomegalovirus Infection and Death after Kidney Transplantation: 476 (2012) (0)
- A Statistical Analysis of the World Wide Experience of Vascularized Composite Tissue Transplantation of Face, Hand and Knee: Outcome, Function, and Late Allograft Loss.: Abstract# D3094 (2014) (0)
- AZATHIOPRINE VS. MYCOPHENOLATE MOFETIL IN GERIATRIC RENAL TRANSPLANT RECIPIENTS (1999) (0)
- INCREASED RECIPIENT AGE IS AN INDEPENDENT RISK FACTOR FOR CHRONIC RENAL ALLOGRAFT FAILURE.: Abstract# 971 (2000) (0)
- External Validation of Kidney Donor Risk Index Does Not Mitigate Its Basic Limitations. (2018) (0)
- Removal of Anti-Thymocyte Globulin by Plasma Exchange in ABO-Incompatible and Positive Crossmatch Kidney Transplant Recipients. (2021) (0)
- MYCOPHENOLATE MOFETIL DECREASES THE RISK OF CHRONIC RENAL ALLOGRAFT FAILURE.: Abstract# 359 (2000) (0)
- CARDIOVASCULAR BENEFITS OF KIDNEY VERSUS SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION (2004) (0)
- A model for calculating the long-term estimated post-transplant survival of deceased donor liver transplant patients (2023) (0)
- Role of PCR in the diagnosis and management of CMV in solid organ recipients: what is the predictive value for the development of disease and should PCR be used to guide antiviral therapy? (1996) (0)
- Pre-Donation Direct and Indirect Costs for Adults Who Donated a Kidney.: Abstract# A304 (2014) (0)
- On Reporting of the Outcomes from Clinical Trials; a Call to Order. (2018) (0)
- Erratum: Multivariable Regression Models in Clinical Transplant Research: Principles and Pitfalls (Transplantation (2015) 99 (2451-2457)) (2016) (0)
- Metabolic and Hemodynamic Determinants of Exercise with the HeartMate 3 LVAD (2022) (0)
- ACUTE REJECTION IS AN INCREASINGLY IMPORTANT RISK FACTOR FOR THE DEVELOPMENT OF CHRONIC RENAL ALLOGRAFT FAILURE.: Abstract# 967 (2000) (0)
- SIROLIMUS IN COMBINATION WITH CYCLOSPORINE MICROEMULSION VERSUS MYCOPHENOLATE MOFETIL WITH CYCLOSPORINE MICROEMULSION IS ASSOCIATED WITH INCREASED ACUTE REJECTION AND LATE ACUTE REJECTION IN RENAL TRANSPLANT RECIPIENTS (2004) (0)
- Erratum: Renal allograft survival in transplant recipients with focal segmental glomerulosclerosis (American Journal of Transplantation (2003) 3 (64-67)) (2003) (0)
- Therapeutic Corner Therapeutic Monitoring of Mycophenolate Mofetil (2006) (0)
- New agents, new ideas and new (2012) (0)
- GENDER DIFFERENCES IN ETIOLOGY OF RENAL ALLOGRAFT LOSS.: Abstract# 444 Poster Board #‐Session: P84‐II (2000) (0)
- CONCURRENT SESSION 98: CHRONIC ALLOGRAFT NEPHROPATHY / IMMUNOLOGICALLY HIGH-RISK TRANSPLANTATION (2006) (0)
- Renal Transplantation: Introduction (2007) (0)
- A SELECTIVE DEFECT IN NEORAL AND PROGRAF ABSORPTION WITH AN INTESTINAL ALLOGRAFT DUE TO INCREASED MUCOSAL P-GLYCOPROTEIN ACTIVITY (1998) (0)
- Using Behavioral Economics to Increase Transplantation Through Commitments to Donate. (2020) (0)
- New Kid on the Pretransplant Block: IgG Recognizing Apoptotic Cells (2014) (0)
- A PHASE I/II MULTIPLE DOSE STUDY OF HuM291, A HUMANIZED ANTI-CD3 MONOCLONAL ANTIBODY, IN PATIENTS EXPERIENCING RENAL ALLOGRAFT REJECTION (1999) (0)
- ALLOGRAFT LOSS IN RENAL TRANSPLANT RECIPIENTS WITH FABRY'S DISEASE AND ACTIVATED PROTEIN C RESISTANCE.: Abstract# 812 Poster Board #‐Session: P69‐III (2000) (0)
- Letter to the Editor. (2019) (0)
- Abbreviated pharmacokinetic strategy for management of Neoral dosed every 8 hours for adult and pediatric renal transplant patients (1997) (0)
- High-throughput sequencing defines donor and recipient HLA B-cell epitope frequencies for prospective matching in transplantation (2021) (0)
- PHARMACOGENETIC FACTORS AFFECTING MYCOPHENOLATE MOFETIL (MMF) PHARMACOKINETIC AND PHARMACODYNAMIC VARIABILITY IN THE OPTICEPT KIDNEY TRANSPLANT STUDY: PRELIMINARY ANALYSIS: 2759 (2010) (0)
- OUTCOME DIFFERENCES FOR SOLID ORGAN TRANSPLANTATION BETWEEN ADULTS AND CHILDREN WITH CYSTIC FIBROSIS: 2059 (2010) (0)
- Transplant administration—A survey of the roles and responsibilities of kidney and pancreas medical directors of US transplant centers (2021) (0)
- Evolving Issues in Clinical Research (2005) (0)
- Pharmacokinetic and Pharmacodynamic Properties of Mycophenolate (2012) (0)
- The Authors' Reply. (2015) (0)
- Deceased Donor Kidneys from Higher Distressed Communities are Significantly Less Likely to be Utilized for Transplantation. (2023) (0)
- Improved ability to achieve target trough levels with liquid versus capsule tacrolimus in kidney transplant patients with HIV on protease inhibitor‐ or cobicistat‐based regimens (2020) (0)
- A Random Walk Through Large Data: Caveats Regarding the Potential for False Inference. (2016) (0)
- KIDNEY AND LIVER TRANSPLANT IN PATIENTS WITH OXALOSIS: 2355 (2010) (0)
- INCREASED IMMUNOLOGICAL RISK TO BENEFIT RATIO IN ELDERLY RENAL TRANSPLANT RECIPIENTS.: Abstract# 829 Poster Board #‐Session: P86‐III (2000) (0)
- Postoperative fibrinolytic resistance is associated with early allograft dysfunction in liver transplantation: A prospective observational study. (2023) (0)
- Renal allograft survival in patients with oxalosis1 (2002) (0)
- Response to "Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared with lisinopril". (2002) (0)
- DOES DOSING OF MYCOPHENOLATE MOFETIL 500 MG QID VS 1000 MG BID IMPACT EFFICACY AND TOLERABILITY AFTER RENAL TRANSPLANTATION: 961 (2008) (0)
- ALTERED IMMUNOLOGICAL RISK TO BENEFIT RATIO IN AFRICAN AMERICAN RENAL TRANSPLANT RECIPIENTS.: Abstract# 445 Poster Board #‐Session: P85‐II (2000) (0)
- Transplantation: CNIs to mTOR inhibitors—effects on allosensitization? (2014) (0)
- Addressing sex-based disparities in solid organ transplantation in the United States - a conference report. (2023) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Bruce Kaplan?
Bruce Kaplan is affiliated with the following schools:
